Andrew Schmidt

3.9k total citations
30 papers, 267 citations indexed

About

Andrew Schmidt is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Andrew Schmidt has authored 30 papers receiving a total of 267 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 13 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Andrew Schmidt's work include Renal cell carcinoma treatment (14 papers), Economic and Financial Impacts of Cancer (9 papers) and Cancer Genomics and Diagnostics (8 papers). Andrew Schmidt is often cited by papers focused on Renal cell carcinoma treatment (14 papers), Economic and Financial Impacts of Cancer (9 papers) and Cancer Genomics and Diagnostics (8 papers). Andrew Schmidt collaborates with scholars based in United States, Australia and Canada. Andrew Schmidt's co-authors include Toni K. Choueiri, Rana R. McKay, Bradley A. McGregor, Ziad Bakouny, Arlene O. Siefker‐Radtke, Wanling Xie, Amir Mortazavi, Guru Sonpavde, Aradhana M. Venkatesan and Atish D. Choudhury and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Andrew Schmidt

27 papers receiving 264 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrew Schmidt United States	10	126	109	77	66	56	30	267
Renata Colombo Bonadio Brazil	9	162 1.3×	58 0.5×	54 0.7×	50 0.8×	58 1.0×	42	291
Sandip Ganguly India	9	131 1.0×	88 0.8×	41 0.5×	21 0.3×	29 0.5×	52	211
Williams Fernandes Barra Brazil	8	65 0.5×	108 1.0×	97 1.3×	80 1.2×	71 1.3×	28	267
Taylor D. Ellington United States	7	129 1.0×	36 0.3×	42 0.5×	46 0.7×	42 0.8×	9	282
Jianbang Chiang Singapore	10	121 1.0×	31 0.3×	16 0.2×	54 0.8×	49 0.9×	40	265
Ray C. J. Hsu United Kingdom	6	54 0.4×	71 0.7×	54 0.7×	103 1.6×	11 0.2×	7	285
Mohini Varughese United Kingdom	7	81 0.6×	53 0.5×	119 1.5×	30 0.5×	36 0.6×	14	223
Sophia Hsu United States	8	115 0.9×	154 1.4×	160 2.1×	34 0.5×	21 0.4×	16	400
Kathleen M. Aguilar United States	9	97 0.8×	78 0.7×	109 1.4×	31 0.5×	22 0.4×	36	307
María José Lecumberri Spain	8	224 1.8×	93 0.9×	46 0.6×	38 0.6×	24 0.4×	14	333

Countries citing papers authored by Andrew Schmidt

Since Specialization

Citations

This map shows the geographic impact of Andrew Schmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Schmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Schmidt more than expected).

Fields of papers citing papers by Andrew Schmidt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Schmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Schmidt. The network helps show where Andrew Schmidt may publish in the future.

Co-authorship network of co-authors of Andrew Schmidt

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Schmidt. A scholar is included among the top collaborators of Andrew Schmidt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Schmidt. Andrew Schmidt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Navani, Vishal, J. Connor Wells, Devon J. Boyne, et al.. (2022). CABOSEQ: The Effectiveness of Cabozantinib in Patients With Treatment Refractory Advanced Renal Cell Carcinoma: Results From the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC). Clinical Genitourinary Cancer. 21(1). 106.e1–106.e8. 12 indexed citations

Labaki, Chris, Ziad Bakouny, Andrew Schmidt, et al.. (2022). 252P Real-world progression-free survival (rwPFS) and time to next line of therapy (TTNT) as intermediate endpoints for survival in metastatic breast cancer: A real-world experience. Annals of Oncology. 33. S652–S652. 3 indexed citations

Shah, Dimpy P., Pankil Shah, Jeremy L. Warner, et al.. (2022). An update on the overall epidemiology, clinical characteristics, and outcomes from the COVID-19 and Cancer Consortium (CCC19).. Journal of Clinical Oncology. 40(16_suppl). 10565–10565. 1 indexed citations

Labaki, Chris, Andrew Schmidt, Ziad Bakouny, et al.. (2022). Temporal changes in the screening, diagnosis and surgical treatment of genitourinary (GU) malignancies during the COVID-19 pandemic.. Journal of Clinical Oncology. 40(6_suppl). 281–281. 1 indexed citations

Navani, Vishal, Devon J. Boyne, Winson Y. Cheung, et al.. (2022). CABOSEQ: The efficacy of cabozantinib post up-front immuno-oncology combinations in patients with advanced renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).. Journal of Clinical Oncology. 40(6_suppl). 318–318. 4 indexed citations

Labaki, Chris, Ziad Bakouny, Andrew Schmidt, et al.. (2022). Real-world progression-free survival (rwPFS) and time to next line of therapy (TTNT) as intermediate endpoints for survival in metastatic breast cancer: A real-world experience.. Journal of Clinical Oncology. 40(16_suppl). 6520–6520. 3 indexed citations

Roussel, Eduard, Lisa Kinget, Benoit Beuselinck, et al.. (2022). First-line therapy for metastatic renal cell carcinoma with pancreatic metastases: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).. Journal of Clinical Oncology. 40(6_suppl). 317–317. 1 indexed citations

McGregor, Bradley A., Andrew Schmidt, Filipe L.F. Carvalho, et al.. (2021). Cyclophosphamide-associated bladder cancers and considerations for survivorship care: A systematic review. Urologic Oncology Seminars and Original Investigations. 39(10). 678–685. 12 indexed citations

Tucker, Matthew D., Andrew Schmidt, Chih–Yuan Hsu, et al.. (2021). Severe-COVID-19 and mortality among patients (pts) with prostate cancer (PCa) receiving androgen deprivation therapy (ADT).. Journal of Clinical Oncology. 39(6_suppl). 39–39. 6 indexed citations

10.

Gan, Chun Loo, Shaan Dudani, J. Connor Wells, et al.. (2021). Outcomes of first-line (1L) immuno-oncology (IO) combination therapies in metastatic renal cell carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC).. Journal of Clinical Oncology. 39(6_suppl). 276–276. 9 indexed citations

11.

Schmidt, Andrew, Alexandra L. Tabakin, Eric A. Singer, Toni K. Choueiri, & Rana R. McKay. (2021). Next Steps: Sequencing Therapies in Metastatic Kidney Cancer in the Contemporary Era. American Society of Clinical Oncology Educational Book. 41(41). 187–197. 15 indexed citations

12.

Paciotti, Marco, Andrew Schmidt, Praful Ravi, et al.. (2021). Temporal Trends and Predictors in the Use of Stereotactic Body Radiotherapy for Treatment of Metastatic Renal Cell Carcinoma in the U.S. The Oncologist. 26(5). e905–e906. 7 indexed citations

13.

Doroshow, Deborah B., Andrew Schmidt, Ziad Bakouny, et al.. (2020). LBA74 Disparities in cancer during the COVID-19 pandemic: COVID-19 and cancer outcomes study (CCOS). Annals of Oncology. 31. S1204–S1204. 4 indexed citations

14.

Schmidt, Andrew, Paul Bain, & Bradley A. McGregor. (2020). Tissue Based Biomarkers for Metastatic Clear Cell Renal Carcinoma: A Systematic Review. 4(4). 197–210.

15.

Ravi, Praful, Ziad Bakouny, Andrew Schmidt, & Toni K. Choueiri. (2020). Novel Therapeutic Approaches and the Evolution of Drug Development in Advanced Kidney Cancer. The Cancer Journal. 26(5). 464–470. 13 indexed citations

16.

Rubinstein, Samuel M., Ryan C. Lynch, Aakash Desai, et al.. (2020). Severity of Sars-Cov-2 Infection in Patients with Hematologic Malignancies: A COVID-19 and Cancer Consortium (CCC19) Registry Analysis. Blood. 136(Supplement 1). 28–30. 7 indexed citations

17.

Schmidt, Andrew, A. Antón, Shirley Wong, et al.. (2020). Treatment outcomes for patients with metastatic castrate‐resistant prostate cancer following docetaxel for hormone‐sensitive disease. Asia-Pacific Journal of Clinical Oncology. 17(1). 36–42. 6 indexed citations

18.

Schmidt, Andrew, Algemir Lunardi Brunetto, Gilberto Schwartsmann, Rafael Roesler, & Ana Lúcia Abujamra. (2010). Recent Therapeutic Advances for Treating Medulloblastoma: Focus on New Molecular Targets. CNS & Neurological Disorders - Drug Targets. 9(3). 335–348. 16 indexed citations

19.

Schmidt, Andrew, David Taggart, Peter Holz, Peter Temple‐Smith, & A. J. Bradley. (2006). Plasma steroids and steroid-binding capacity in male semelparous dasyurid marsupials (Phascogale tapoatafa) that survive beyond the breeding season in captivity. General and Comparative Endocrinology. 149(3). 236–243. 12 indexed citations

20.

Schmidt, Andrew, et al.. (1982). A Comparison of Male and Female Single Parents in Australia.. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact